Silver Book

Silver Book Fact

Moderate or severe aortic valve disease is present in 4.2% to 10.7% of the population ages 65 and older.

Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving women and elderly patients behind?. Journal of Heart Valve Disease. 2007; 16(4). https://www.medscape.com/medline/abstract/17702360

Nkomo, Vuyisile, Julius Gardin, Thomas Skelton, John Gottdiener, Christopher Scott, Maurice Enriquez-Sarano. Burden of Valvular Heart Diseases: a population-based study. Lancet. September 2006; 368(9540). http://www.ncbi.nlm.nih.gov/pubmed/16980116

Reference

Title
Prevalence, Referral Patterns, Testing, and Surgery in Aortic Valve Disease: Leaving women and elderly patients behind?
Publication
Journal of Heart Valve Disease
Publication Date
2007
Volume & Issue
Volume 16, Issue 4
URL
Read Full Resource
Title
Burden of Valvular Heart Diseases: a population-based study
Publication
Lancet
Publication Date
September 2006
Authors
Nkomo, Vuyisile, Julius Gardin, Thomas Skelton, John Gottdiener, Christopher Scott, Maurice Enriquez-Sarano
Volume & Issue
Volume 368, Issue 9540
Pages
1005-11
URL
Read Full Resource

Categories

  • Cost of Disease
  • Age - A Major Risk Factor

Publications

Silver Book: Valve Disease Volume

 https://www.silverbook.org/wp-content/uploads/2018/02/SB-Vol-TN.jpg Thumbnail

Connected Facts

Mitral Valve Disease

Mitral valve disease is present in 5.1% of the population ages 65 and older.
Age - A Major Risk Factor

Valve Disease

Risk of heart valve disease increases with age

Between the ages of 18 and 44, less than 1% of the U.S. population has heart valve disease. This increases to 8.5% between ages 65 and 74, and 13.2% after age 75.

Age - A Major Risk Factor, Human Burden

Valve Disease

Prevalence estimates for heart valve disease are likely low.

A U.K. population screening found previously undetected heart valve disease in 1 in 2 adults ages 65+.

Aortic Stenosis

Fact image
Aortic stenosis often undertreated
Cost of Disease

Related Facts

  • Mean 5-Year Cumulative Total Medical Costs Per Medically Managed (No AVR) Severe AS Patient
     
  • Survival rates for SAS patients without treatment
     
  • 1 and 6-month mortality rates without treatment for sSAS
    Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).  
  • Prevalence of AS in Americans 75+
    An estimated 12.4%, or ~2.5 million people ages 75+ in North America, have AS.  
  • Five-year health care resource use in medically managed SAS patients